October 3, 2019

This guide from SAMHSA, offers guidance on the use of medication-assisted treatment (MAT) with extended-release injectable naltrexone for the treatment of an opioid use disorder.

Covers patient assessment, initiating MAT, monitoring progress, and deciding when to end treatment.

View Resource